Editorial
Editors’ page The Editors* *[email protected] DOI: http://dx.doi.org/10.5339/gcsp.2014.33 Submitted: 30 September 2014 Accepted: 30 September 2014 Running head: The Editors. GCSP 2014:33 Cite this article as: The Editors. Editors' page, Global Cardiology Science and Practice 2014:33 http://dx.doi.org/10.5339/gcsp.2014.33 Copyright: 2014 The Editors, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY-4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. THIS PROVISIONAL PDF CORRESPONDS TO THE AUTHOR-SUPPLIED ARTICLE AS IT WAS ACCEPTED. FULLY FORMATTED PDF AND HTML VERSIONS WILL BE MADE AVAILABLE SOON.
This peer-reviewed article, like all on QScience.com, was published immediately upon acceptance. It can be downloaded, printed and distributed freely provided the original work is properly attributed. For information about publishing your research in QScience.com journals, please go to http://authorsqscience.com/
Editorial)
) )
Editors’)page) )
The)Editors*) ) *[email protected] ) ) In)this)issue)of)the)journal)we)highlight)important)and)controversial)issues)which)affect) patient)management.)There)is)currently)an)ongoing)debate)about)the)use)of)Dabigatran) and)the)lack)of)need)for)monitoring)the)level)of)anticoagulation,)which)has)previously) been)claimed)to)one)of)the)most)important)advantages)of)the)drug.)Furthermore,)the)REA LY)study)has)come)under)scrutiny,)as)has)the)drug)company’s)disclosure)of)data)and)the) FDA’s)handling)of)the)issue.) ) All)these)issues)have)been)highlighted)in)detail)by)Dr)Kaba)and)colleagues)in)their)News) And)Views)article.)We)invite)comments)from)the)readership)about)the)issues)raised)in) this)important)article.) )
Copyright of Global Cardiology Science & Practice is the property of Bloomsbury Qatar Foundation Journals and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
Editors’ page The Editors* *[email protected] DOI: http://dx.doi.org/10.5339/gcsp.2014.33 Submitted: 30 September 2014 Accepted: 30 September 2014 Running head: The Editors. GCSP 2014:33 Cite this article as: The Editors. Editors' page, Global Cardiology Science and Practice 2014:33 http://dx.doi.org/10.5339/gcsp.2014.33 Copyright: 2014 The Editors, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY-4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. THIS PROVISIONAL PDF CORRESPONDS TO THE AUTHOR-SUPPLIED ARTICLE AS IT WAS ACCEPTED. FULLY FORMATTED PDF AND HTML VERSIONS WILL BE MADE AVAILABLE SOON.
This peer-reviewed article, like all on QScience.com, was published immediately upon acceptance. It can be downloaded, printed and distributed freely provided the original work is properly attributed. For information about publishing your research in QScience.com journals, please go to http://authorsqscience.com/
Editorial)
) )
Editors’)page) )
The)Editors*) ) *[email protected] ) ) In)this)issue)of)the)journal)we)highlight)important)and)controversial)issues)which)affect) patient)management.)There)is)currently)an)ongoing)debate)about)the)use)of)Dabigatran) and)the)lack)of)need)for)monitoring)the)level)of)anticoagulation,)which)has)previously) been)claimed)to)one)of)the)most)important)advantages)of)the)drug.)Furthermore,)the)REA LY)study)has)come)under)scrutiny,)as)has)the)drug)company’s)disclosure)of)data)and)the) FDA’s)handling)of)the)issue.) ) All)these)issues)have)been)highlighted)in)detail)by)Dr)Kaba)and)colleagues)in)their)News) And)Views)article.)We)invite)comments)from)the)readership)about)the)issues)raised)in) this)important)article.) )
Copyright of Global Cardiology Science & Practice is the property of Bloomsbury Qatar Foundation Journals and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
